KALEB GRIMES: Open Payments
NPI 1609599430 · CORDOVA, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$709 in 34 payments from 14 companies in 2025. Trend: 2023 $20 · 2024 $1,062 · 2025 $709
Food & beverage: $709
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 8 | $183 |
| Lilly USA, LLC | 4 | $78 |
| Novo Nordisk Inc | 3 | $73 |
| Otsuka America Pharmaceutical, Inc. | 3 | $69 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $65 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $34 |
| Aimmune Therapeutics, Inc. | 2 | $33 |
| ABBVIE INC. | 1 | $31 |
| Exact Sciences Corporation | 2 | $29 |
| Seqirus USA Inc | 1 | $27 |
Products named: AIRSUPRA, JARDIANCE, BREZTRI, REXULTI, CAPLYTA, Ozempic, ZENPEP, UBRELVY.
Industry payments across TN — which companies pay providers there.
